• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向NLRP3炎性小体中NACHT/PYD结构域的植物化学生物碱的计算药物发现

Computational drug discovery of phytochemical alkaloids targeting the NACHT/PYD domain in the NLRP3 inflammasome.

作者信息

Singh Nilay, Sharma Promila, Pal Manoj K, Kahera Ragini, Badoni Himani, Pant Kumud, Sharma Neetu, Bhist Bhawana

机构信息

Department of Biotechnology, Graphic Era (Deemed to be University), 566/6 Bell Road, Clement Town, Dehradun, Uttarakhand, India.

Department of Microbiology, Graphic Era (Deemed to be University), 566/6 Bell Road, Clement Town, Dehradun, Uttarakhand, India.

出版信息

Sci Rep. 2025 May 14;15(1):16677. doi: 10.1038/s41598-024-79054-2.

DOI:10.1038/s41598-024-79054-2
PMID:40368915
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12078577/
Abstract

The NLRP3 inflammasome plays a pivotal role in the innate immune system, orchestrating the activation of caspase-1 and the release of proinflammatory cytokines IL-1β and IL-18 in reaction to microbial infections and cellular damage. Despite its crucial function in defending against pathogens, the dysregulated activation of the NLRP3 inflammasome has been associated with various inflammatory disorders. In the current investigation, promising plant-derived alkaloids compounds have been discovered as targeted inhibitors against multiprotein NLRP3 using an in-silico drug development approach. The repurposing of natural compounds as anti-inflammatory agents remains a relevant approach for identifying promising early interventions to prevent and manage inflammatory diseases. In this molecular docking study targeting Chain A of the NLRP3 inflammasome protein, eight plant-derived alkaloids renowned for their anti-inflammatory properties were chosen. Docking analysis of the selected alkaloids showed the lowest/best binding energies of less than - 10 Kcal/mol against NLRP3 Chain A, based on this docking result, which is regarded as an exceptional binding score. Notably, Oxyacanthine, Magnoflorine, Corynoline, and Berbamine demonstrated the most favourable binding energies, displaying unique interactions within the binding pocket of the NACHT/PYD domain of NLRP3 Chain A among all compounds investigated. These findings highlight the potential of these alkaloids as promising therapeutic candidates specifically targeting this trans-activating NACHT/PYD domain of NLRP3 Chain A in the context of anti-inflammatory interventions. Protein-protein interactions (PPIs) play an important role in elucidating protein function and drug interactions. To identify bioactive compounds with anti-inflammatory potential, a functional protein network was constructed from publicly available PPI data. As a result, the findings of this in-silico study may cause researchers to emphasize more on alkaloids when considering natural plant products for the treatment of various illnesses that target the inflammatory intermediates. This computational approach predicted ligands that may modulate inflammatory proteins and support host immunity. However, further in vitro and in vivo studies are still needed to validate these in-silico findings before clinical use. In summary, analysing PPI networks can aid discovery of therapeutic candidates, but experimental validation remains essential.

摘要

NLRP3炎性小体在先天免疫系统中起关键作用,在对微生物感染和细胞损伤的反应中,协调半胱天冬酶-1的激活以及促炎细胞因子IL-1β和IL-18的释放。尽管其在抵御病原体方面具有关键功能,但NLRP3炎性小体的失调激活与多种炎症性疾病有关。在当前的研究中,使用计算机辅助药物开发方法发现了有前景的植物源生物碱化合物作为针对多蛋白NLRP3的靶向抑制剂。将天然化合物重新用作抗炎剂仍然是确定有前景的早期干预措施以预防和管理炎症性疾病的一种相关方法。在这项针对NLRP3炎性小体蛋白A链的分子对接研究中,选择了八种以其抗炎特性而闻名的植物源生物碱。所选生物碱的对接分析显示,基于该对接结果,其与NLRP3 A链的最低/最佳结合能小于-10千卡/摩尔,这被视为优异的结合分数。值得注意的是,在所有研究的化合物中,氧化刺桐碱、木兰碱、紫堇灵和小檗胺表现出最有利的结合能,在NLRP3 A链的NACHT/PYD结构域的结合口袋内显示出独特的相互作用。这些发现突出了这些生物碱作为有前景的治疗候选物的潜力,特别是在抗炎干预的背景下靶向NLRP3 A链的这种反式激活NACHT/PYD结构域。蛋白质-蛋白质相互作用(PPI)在阐明蛋白质功能和药物相互作用中起重要作用。为了鉴定具有抗炎潜力的生物活性化合物,从公开可用的PPI数据构建了一个功能性蛋白质网络。结果,这项计算机辅助研究的发现可能会使研究人员在考虑将天然植物产品用于治疗针对炎症中间体的各种疾病时,更多地强调生物碱。这种计算方法预测了可能调节炎症蛋白并支持宿主免疫的配体。然而,在临床使用之前,仍需要进一步的体外和体内研究来验证这些计算机辅助研究的结果。总之,分析PPI网络有助于发现治疗候选物,但实验验证仍然至关重要。

相似文献

1
Computational drug discovery of phytochemical alkaloids targeting the NACHT/PYD domain in the NLRP3 inflammasome.靶向NLRP3炎性小体中NACHT/PYD结构域的植物化学生物碱的计算药物发现
Sci Rep. 2025 May 14;15(1):16677. doi: 10.1038/s41598-024-79054-2.
2
Identification of anti-inflammatory and anti-cancer compounds targeting the NF-κB-NLRP3 inflammasome pathway from a phytochemical library of the Sideritis genus.从铁角蕨属植物化学文库中鉴定靶向NF-κB-NLRP3炎性小体途径的抗炎和抗癌化合物。
J Ethnopharmacol. 2025 Feb 10;338(Pt 2):119074. doi: 10.1016/j.jep.2024.119074. Epub 2024 Nov 9.
3
High-Throughput Molecular Modeling and Evaluation of the Anti-Inflammatory Potential of Açaí Constituents against NLRP3 Inflammasome.高通量分子模拟与评价阿萨伊成分对 NLRP3 炎性小体的抗炎潜力。
Int J Mol Sci. 2024 Jul 25;25(15):8112. doi: 10.3390/ijms25158112.
4
Computational screening of coumarin derivatives as inhibitors of the NACHT domain of NLRP3 inflammasome for the treatment of Alzheimer's disease.香豆素衍生物作为NLRP3炎性小体NACHT结构域抑制剂用于治疗阿尔茨海默病的计算筛选
J Biomol Struct Dyn. 2025 Mar;43(5):2187-2203. doi: 10.1080/07391102.2023.2294173. Epub 2023 Dec 20.
5
Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.天然产物和药物对NLRP3炎性小体的治疗靶向作用:一种针对炎症性疾病的新型机制方法。
Curr Med Chem. 2017;24(16):1645-1670. doi: 10.2174/0929867324666170227121619.
6
POP1 might be recruiting its type-Ia interface for NLRP3-mediated PYD-PYD interaction: Insights from MD simulation.POP1可能正在为NLRP3介导的PYD-PYD相互作用募集其I型a界面:来自分子动力学模拟的见解。
J Mol Recognit. 2017 Sep;30(9). doi: 10.1002/jmr.2632. Epub 2017 Apr 3.
7
Predicting Multi-Interfacial Binding Mechanisms of NLRP3 and ASC Pyrin Domains in Inflammasome Activation.预测 NLRP3 和 ASC 吡喃结构域在炎症小体激活中的多界面结合机制。
ACS Chem Neurosci. 2021 Feb 17;12(4):603-612. doi: 10.1021/acschemneuro.0c00519. Epub 2021 Jan 27.
8
Discovery, Total Synthesis, and Anti-Inflammatory Evaluation of Naturally Occurring Naphthopyrone-Macrolide Hybrids as Potent NLRP3 Inflammasome Inhibitors.天然萘并吡喃酮-大环内酯类杂种的发现、全合成及抗炎活性评价作为强效 NLRP3 炎性体抑制剂。
Angew Chem Int Ed Engl. 2024 Oct 21;63(43):e202405860. doi: 10.1002/anie.202405860. Epub 2024 Jul 17.
9
Identification of NLRP3 Homo-Oligomerization Inhibitors with Anti-Inflammatory Activity.鉴定具有抗炎活性的 NLRP3 同源寡聚抑制剂。
Int J Mol Sci. 2022 Jan 31;23(3):1651. doi: 10.3390/ijms23031651.
10
Human NACHT, LRR, and PYD domain-containing protein 3 (NLRP3) inflammasome activity is regulated by and potentially targetable through Bruton tyrosine kinase.人 NACHT、LRR 和 PYD 结构域包含蛋白 3(NLRP3)炎症小体的活性受布鲁顿酪氨酸激酶调节,并且可能成为其作用靶点。
J Allergy Clin Immunol. 2017 Oct;140(4):1054-1067.e10. doi: 10.1016/j.jaci.2017.01.017. Epub 2017 Feb 16.

本文引用的文献

1
Phytochemicals in the treatment of inflammation-associated diseases: the journey from preclinical trials to clinical practice.植物化学物质在炎症相关疾病治疗中的应用:从临床前试验到临床实践的历程。
Front Pharmacol. 2023 May 9;14:1177050. doi: 10.3389/fphar.2023.1177050. eCollection 2023.
2
KEGG for taxonomy-based analysis of pathways and genomes.KEGG 用于基于分类的途径和基因组分析。
Nucleic Acids Res. 2023 Jan 6;51(D1):D587-D592. doi: 10.1093/nar/gkac963.
3
Berberine: A Review of its Pharmacokinetics Properties and Therapeutic Potentials in Diverse Vascular Diseases.
小檗碱:其药代动力学特性及在多种血管疾病中的治疗潜力综述
Front Pharmacol. 2021 Nov 3;12:762654. doi: 10.3389/fphar.2021.762654. eCollection 2021.
4
Pharmacological Applications and Action Mechanisms of Phytochemicals as Alternatives to Antibiotics in Pig Production.植物化学物质作为抗生素替代品在猪生产中的药理应用和作用机制。
Front Immunol. 2021 Dec 9;12:798553. doi: 10.3389/fimmu.2021.798553. eCollection 2021.
5
Tranilast: a potential anti-Inflammatory and NLRP3 inflammasome inhibitor drug for COVID-19.曲尼司特:一种用于治疗新型冠状病毒肺炎的潜在抗炎和NLRP3炎性小体抑制剂药物。
Immunopharmacol Immunotoxicol. 2021 Jun;43(3):247-258. doi: 10.1080/08923973.2021.1925293. Epub 2021 May 21.
6
Targeting the NLRP3 inflammasome as new therapeutic avenue for inflammatory bowel disease.针对 NLRP3 炎性小体作为炎症性肠病的新治疗靶点。
Biomed Pharmacother. 2021 Jun;138:111442. doi: 10.1016/j.biopha.2021.111442. Epub 2021 Mar 2.
7
Physicochemical characterisation, molecular docking, and drug-likeness evaluation of hypotensive peptides encrypted in flaxseed proteome.亚麻籽蛋白质组中加密的降压肽的物理化学表征、分子对接及类药性评估
Curr Res Food Sci. 2020 Mar 14;3:41-50. doi: 10.1016/j.crfs.2020.03.001. eCollection 2020 Nov.
8
Magnoflorine: A review of its pharmacology, pharmacokinetics and toxicity.厚朴碱:药理学、药代动力学和毒理学综述。
Pharmacol Res. 2020 Feb;152:104632. doi: 10.1016/j.phrs.2020.104632. Epub 2020 Jan 3.
9
The NLRP3 inflammasome: a new player in neurological diseases.NLRP3炎性小体:神经疾病中的新角色。
Turk J Biol. 2019 Dec 13;43(6):349-359. doi: 10.3906/biy-1909-31. eCollection 2019.
10
The Pyrin Inflammasome in Health and Disease.Pyrin 炎症小体在健康与疾病中的作用
Front Immunol. 2019 Aug 7;10:1745. doi: 10.3389/fimmu.2019.01745. eCollection 2019.